ARCHIVES

Kirsten Goldberg Leaves The Cancer Letter For ASCO

This article is from The Cancer Letter archive.

Vol. 37 No. 01 | January 7, 2011

Download PDF Visit The Full Archive

Related Articles

Advisors Ok New RFP For Natural Product Large-Scale Production

March 6, 1992

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

September 18, 1987

Research Funding In Crisis; Scientists Fear Cancer Program’s Dismantling, AACR Says

January 20, 1995

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

February 17, 2006

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

Rogers Bill Would Authorize $937 Million For NCI In ‘78

March 4, 1977